Breaking News
Zymeworks to acquire troubled biotech Theravance in $929M deal
Biotech Biotech Headlines

Zymeworks to acquire troubled biotech Theravance in $929M deal

Source: news.google.com

Published: Jun 29, 2026 11:13

Read Original Source
Zymeworks to acquire troubled biotech Theravance in $929M deal  Endpoints News
Detailed source content is still being fetched from the original article. Use the source link above for the live story.

Related Stories

More from this topic and section

Add Shortcut

Add Newsfeed to your home screen

Open this site faster like an app from your phone home screen.

X in 3s